Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Ajax Therapeutics
company
About
Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $40M
- Industries
- Biotechnology,Life Science,Medical
- Founded date
- Jan 1, 2019
- Operating Status
- Active
Ajax Therapeutics is an NYC-based biotechnology company applying computational chemistry and structure-based technologies to develop novel small molecules for hematologic malignancies
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$40M
Ajax Therapeutics has raised a total of
$40M
in funding over 2 rounds. Their latest funding was raised on
Jun 1, 2021 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 1, 2021 | Series Unknown | $40M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Ajax Therapeutics is funded by 2 investors.
Schrödinger
and Inning One Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Schrödinger
|
— | Series Unknown |
|
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
